Cognitive Enhancing Drugs

  • Jerry J. Buccafusco

Part of the Milestones in Drug Therapy MDT book series (MDT)

Table of contents

  1. Front Matter
    Pages I-XII
  2. Jerry J. Buccafusco
    Pages 1-10
  3. Ezio Giacobini
    Pages 11-36
  4. William S. Messer Jr.
    Pages 37-48
  5. Edward D. Levin
    Pages 69-77
  6. Alvin V. Terry Jr.
    Pages 79-88
  7. Arthur A. Hancock, Gerard B. Fox
    Pages 97-114
  8. Joe L. Martinez Jr., Kenira Thompson, Melanie P. McFadyen-Leussis, Stephen C. Heinrichs
    Pages 115-149
  9. Keith A. Wesnes, Andrea Zangara, Andrew Scholey, David Kennedy
    Pages 151-178
  10. Jerry J. Buccafusco, Moussa B. H. Youdim
    Pages 179-198
  11. Back Matter
    Pages 199-203

About this book


During the past decade research into the pharmacology of cognition, particularly regarding learning and memory, has supported the concept that many potential neural targets exist for the development of cognitive-enhancing drugs. Whereas the main impetus for this research has been the ever growing population of individuals with dementing disorders such as Alzheimer`s disease, attention is also being focused on issues relating to cognitive impairment associated with "normal" aging. This book is useful as a source of information for making informed decisions regarding the relative utility and attributes of the various neural targets that have been studied to date.


Alzheimer attention cholinesterase cns cognitive disorders functional brain imaging learning and memory processes neural drug targets neuropeptide/hormone receptors neurotransmitter receptors pharmacotherapy

Editors and affiliations

  • Jerry J. Buccafusco
    • 1
  1. 1.Medical College of Georgia, Department of Pharmacology and ToxicologyAlzheimer’s Research CenterAugustaUSA

Bibliographic information

Industry Sectors
Chemical Manufacturing
Health & Hospitals
Pharmacology & Toxicology
Consumer Packaged Goods